Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arndt Hartmann

Showing results (471-480 of 933) with videos related to

Pageof 94
Sort By:
International Journal of Molecular Sciences|November 6, 2020
Tumour-Infiltrating Inflammatory Cells in Early Breast Cancer: An Underrated Prognostic and Predictive Factor?Sören Schnellhardt, Ramona Erber, Maike Büttner-Herold, et al.
The Journal of Molecular Diagnostics : JMD|May 2, 2024
Quality-Assured Analysis of PIK3CA Mutations in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer TissueCarolin Schmidt, Robert Stöhr, Lora Dimitrova, et al.
American Journal of Clinical Pathology|December 29, 2016
Inactivating Mutations of RB1 and TP53 Correlate With Sarcomatous Histomorphology and Metastasis/Recurrence in Gastrointestinal Stromal TumorsLarissa Merten, Abbas Agaimy, Evgeny A Moskalev, et al.
Oncology Letters|January 2, 2016
Positive fibroblast growth factor receptor 3 immunoreactivity is associated with low-grade non-invasive urothelial bladder cancerCédric Poyet, Thomas Hermanns, Qing Zhong, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 13, 2020
Variant morphology and random chromosomal integration of BK polyomavirus in posttransplant urothelial carcinomasSimone Bertz, Armin Ensser, Robert Stoehr, et al.
Archives of Gynecology and Obstetrics|December 8, 2019
Correlation between referral cytology and in-house colposcopy-guided cytology for detecting early cervical neoplasiaCarla E Schulmeyer, Frederik Stübs, Paul Gass, et al.
Gastroenterology|October 24, 2022
Intestinal Barrier Healing Is Superior to Endoscopic and Histologic Remission for Predicting Major Adverse Outcomes in Inflammatory Bowel Disease: The Prospective ERIca TrialTimo Rath, Raja Atreya, Julia Bodenschatz, et al.
BMC Cancer|September 28, 2018
Addition of triple negativity of breast cancer as an indicator for germline mutations in predisposing genes increases sensitivity of clinical selection criteriaJuliane Hoyer, Georgia Vasileiou, Steffen Uebe, et al.
Histopathology|June 6, 2014
Fibroblast growth factor receptor (FGFR) gene amplifications are rare events in bladder cancerAnna Fischbach, Anja Rogler, Ramona Erber, et al.
International Journal of Molecular Sciences|June 27, 2024
Prognostic and Predictive Potential of CCL5 Expression in Muscle-Invasive Bladder Cancer PatientsCedric Smolka, Markus Eckstein, Rudolf Jung, et al.
Pageof 94

Showing results (471-480 of 933) with videos related to

Sort By:
Pageof 94
International Journal of Molecular Sciences|November 6, 2020
Tumour-Infiltrating Inflammatory Cells in Early Breast Cancer: An Underrated Prognostic and Predictive Factor?Sören Schnellhardt, Ramona Erber, Maike Büttner-Herold, et al.
The Journal of Molecular Diagnostics : JMD|May 2, 2024
Quality-Assured Analysis of PIK3CA Mutations in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer TissueCarolin Schmidt, Robert Stöhr, Lora Dimitrova, et al.
American Journal of Clinical Pathology|December 29, 2016
Inactivating Mutations of RB1 and TP53 Correlate With Sarcomatous Histomorphology and Metastasis/Recurrence in Gastrointestinal Stromal TumorsLarissa Merten, Abbas Agaimy, Evgeny A Moskalev, et al.
Oncology Letters|January 2, 2016
Positive fibroblast growth factor receptor 3 immunoreactivity is associated with low-grade non-invasive urothelial bladder cancerCédric Poyet, Thomas Hermanns, Qing Zhong, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 13, 2020
Variant morphology and random chromosomal integration of BK polyomavirus in posttransplant urothelial carcinomasSimone Bertz, Armin Ensser, Robert Stoehr, et al.
Archives of Gynecology and Obstetrics|December 8, 2019
Correlation between referral cytology and in-house colposcopy-guided cytology for detecting early cervical neoplasiaCarla E Schulmeyer, Frederik Stübs, Paul Gass, et al.
Gastroenterology|October 24, 2022
Intestinal Barrier Healing Is Superior to Endoscopic and Histologic Remission for Predicting Major Adverse Outcomes in Inflammatory Bowel Disease: The Prospective ERIca TrialTimo Rath, Raja Atreya, Julia Bodenschatz, et al.
BMC Cancer|September 28, 2018
Addition of triple negativity of breast cancer as an indicator for germline mutations in predisposing genes increases sensitivity of clinical selection criteriaJuliane Hoyer, Georgia Vasileiou, Steffen Uebe, et al.
Histopathology|June 6, 2014
Fibroblast growth factor receptor (FGFR) gene amplifications are rare events in bladder cancerAnna Fischbach, Anja Rogler, Ramona Erber, et al.
International Journal of Molecular Sciences|June 27, 2024
Prognostic and Predictive Potential of CCL5 Expression in Muscle-Invasive Bladder Cancer PatientsCedric Smolka, Markus Eckstein, Rudolf Jung, et al.
Pageof 94